warfarin
Identification (Source:EPA,EU)
ID |
1774 |
Name |
warfarin |
CAS |
81-81-2 |
IUPAC |
|
Inchi |
InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3 |
CIPAC |
70 |
EPA Code |
086002 |
Formula |
C19H16O4 |
SMILES |
O=C\1c3c(OC(/O)=C/1C(c2ccccc2)CC(=O)C)cccc3 |
Status |
Approved |
Classification
Mode of Action |
1st generation anticoagulant |
Pesticide Type |
Rodenticide |
Chemical Group |
Coumarin anticoagulant |
Classification |
coumarin rodenticides
|
Properties (Source:PubChem)
Molecular Weight |
308.33 |
Physical State |
Colourless to white crystalline powder |
AlogP |
3.292 |
H-Bond Donor |
1 |
H-Bond Acceptor |
4 |
Surface Area |
291.15 |
Polar Surface Area |
63.6 |
Structure
Ecotoxicology (Source:PPDB,IPM)
Species |
Method |
Study Time |
Dose Type |
Value |
Algae |
Acute |
72 hour |
EC50, growth |
> 8.5 mg l-1 |
Algae |
Chronic |
96 hour |
NOEC, growth |
8.5 mg l-1 |
Aquatic invertebrates |
Acute |
48 hour |
EC50 |
> 105 mg l-1 |
Birds |
Short term dietary |
|
LC50/LD50 |
4448 mg/kg feed |
Birds |
Acute |
|
LD50 |
> 2000 mg kg-1 |
Fish |
Chronic |
21 day |
NOEC |
2.0 mg l-1 |
Fish |
Acute |
96 hour |
LC50 |
65.0 mg l-1 |
Mammals |
Acute oral |
|
LD50 |
10.4 mg kg-1 |
Related targets
Target Name |
RScore (About this table) |
|
CYP2C9
|
5206(34,72,246,476) |
Details |
VKORC1
|
4191(23,51,258,476) |
Details |
CYP450 (protein family or complex)
|
1432(13,23,29,62) |
Details |
prothrombin
|
2346(12,42,85,271) |
Details |
albumin
|
472(5,6,8,32) |
Details |
osteocalcin
|
343(4,4,5,18) |
Details |
statins
|
461(3,8,15,36) |
Details |
protein Z
|
311(3,5,5,11) |
Details |
IL 6
|
245(3,3,3,5) |
Details |
CYP2C19
|
288(2,4,11,33) |
Details |
Gla domain
|
196(2,3,3,6) |
Details |
growth arrest specific protein 6
|
178(2,2,2,18) |
Details |
matrix Gla protein
|
169(2,2,2,9) |
Details |
Factor Xa
|
326(1,7,8,61) |
Details |
CYP3A4
|
212(1,4,7,27) |
Details |
GGCX
|
194(1,4,6,14) |
Details |
thromboplastin
|
174(1,3,4,29) |
Details |
factor VIIa
|
170(1,2,9,25) |
Details |
protein a
|
162(1,2,6,32) |
Details |
vitamin K epoxide reductase complex (protein family or complex)
|
144(1,2,7,9) |
Details |
hemoglobin (protein family or complex)
|
141(1,2,3,26) |
Details |
CYP1A2
|
134(1,2,4,14) |
Details |
alpha 1 acid glycoprotein
|
120(1,2,3,5) |
Details |
cancer procoagulant
|
114(1,2,2,4) |
Details |
GLUC
|
114(1,2,2,4) |
Details |
PF4
|
94(1,1,1,14) |
Details |
periostin
|
89(1,1,1,9) |
Details |
UGT1A1
|
89(1,1,2,4) |
Details |
FVIII
|
87(1,1,1,7) |
Details |
CYP2E1
|
86(1,1,1,6) |
Details |
CYP2C8
|
83(1,1,1,3) |
Details |
CYP1A1
|
82(1,1,1,2) |
Details |
p70
|
82(1,1,1,2) |
Details |
proton pump
|
289(0,9,9,19) |
Details |
cytochrome P450 4F2
|
283(0,5,23,43) |
Details |
apolipoprotein E
|
71(0,2,3,6) |
Details |
cyclooxygenase 2
|
62(0,2,2,2) |
Details |
CALU
|
59(0,1,5,9) |
Details |
CYP2D6
|
47(0,1,2,12) |
Details |
calcium channel (protein family or complex)
|
40(0,1,2,5) |
Details |
P glycoprotein
|
39(0,1,1,9) |
Details |
angiotensin II
|
36(0,1,1,6) |
Details |
interleukin 15
|
36(0,1,1,6) |
Details |
CD34
|
35(0,1,1,5) |
Details |
NK 1 receptor
|
32(0,1,1,2) |
Details |
prostaglandin D2 receptor
|
32(0,1,1,2) |
Details |
CD56
|
32(0,1,1,2) |
Details |
BP 1
|
32(0,1,1,2) |
Details |
cytochrome c
|
31(0,1,1,1) |
Details |
sulfotransferases (protein family or complex)
|
31(0,1,1,1) |
Details |
STAT5
|
31(0,1,1,1) |
Details |
EPHX1
|
32(0,0,5,7) |
Details |
WICH
|
30(0,0,4,10) |
Details |
tissue plasminogen activator
|
27(0,0,3,12) |
Details |
Docunmentation of Network Visuallization
Network initializing...Please wait
Legend:
: Current entry node;
: Target node;
: Compound node;